SCHEMBL27367479

SCHEMBL27367479

COc1ccccc1-c1c(N(C(N)=O)c2cccc3cccnc23)c(=O)n(C)c2ncccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK10 O94804 1/20 0.41
SLK Q9H2G2 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
TACR1 P25103 1/20 0.37
PRKCB P05771 2/20 0.37
GSK3B P49841 2/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 3/20 0.36
POLB P06746 2/20 0.36
MAP2 P11137 1/20 0.36
HCRTR1 O43613 1/20 0.36
DPP4 P27487 1/20 0.35
TP53 P04637 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27534236 0.88 POLB (0.41) MEN1KMT2ARAB9ATACR1PRKCB
SCHEMBL27392325 0.87 TACR1 (0.40) LMNAMAPTTACR1PRKCBGSK3B
SCHEMBL27368420 0.87 KDM4E (0.39) RAB9ATACR1PRKCBGSK3BALDH1A1
SCHEMBL27393240 0.83 JAK2 (0.40) MEN1KMT2ADPP4
SCHEMBL27392323 0.80 MAP2 (0.40) MEN1KMT2ARAB9ALMNAMAPT
SCHEMBL27398847 0.78 KDM4E (0.38) MAPTTACR1PRKCBGSK3BKDM4E
SCHEMBL6634786 0.74 PRKCB (0.44) RAB9ATACR1PRKCBGSK3BALDH1A1
SCHEMBL27389832 0.73 RXFP1 (0.42) KMT2ALMNAMAPTDPP4
SCHEMBL27370786 0.72 TP53 (0.43) KMT2AMAPTDPP4TP53
SCHEMBL27366469 0.72 ACAT1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1065243-C Naphthyridine derivs. SUMITOMO PHARMA (JP) 2001-05-02 CN disclosed
CN-1191536-A Naphthyridine derivs. SUMITOMO PHARMA (JP) 1998-08-26 CN disclosed